Yahoo Finance Singapore. Illumina (NasdaqGS:ILMN) has been chosen to perform whole genome sequencing for Singapore. SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare.